3106269129

enhances glioma virotherapy by inhibiting innate immune responses. Proceedings of the National Acaderay of Sciences 103,12873-12878.

Galanis, E., Markovic, S.N., Suman, V.J., Nuovo, G.J., Vile, R.G., Kottke, T.J., Nevala, W.K., Thompson, M.A., Lewis, J.E., Rumilla, K.M., et al. (2012). Phase II trial of intravenous administration of Reolysin[reg] (Reovirus serotype-3-dearing strain) in patients with metastatic melanoma. Mol. Ther. 20, 1998-2003.

Garcia-Sastre, A., and Biron, C.A. (2006). Type 1 interferons and the virus-host relationship: A lesson in detente. Science 3/2, 879-882.

Ge, P., Tsao, J., Schein, S , Green, T.J., Luo, M., and Zhou, Z.H. (2010). Cryo-EM Model of the Bullet-Shaped Vesicular Stomatitis Virus. Science 327, 689-693.

Genin, P., Lin, R., Hiscott, J., and Civas, A. (2012). Recruitment of Histone Deacetylase 3 to the Interferon-A Gene Promoters Attenuates Interferon Expression. PLoS ONE 7, e38336.

Georgel, P., Jiang, Z., Kunz, S., Janssen, E., Mols, J., Hoebe, K., Bahram, S., Oldstone, M.B.A., and Beutler, B. (2007). Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362, 304-313.

Guo, Z.S., Thome, S.H., and Bartlett, D.L. (2008). Oncolytic virotherapy: Molecular targets in tumor-selective replication and cairier cell-mediated delivery of oncolytic viruses. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1785, 217-231.

Higuchi, H., Bronk, S.F., Bateman, A., Harrington, K., Vile, R.G., and Gores, G.J. (2000). Viral Fusogenic Membranę Glycoprotein Expression Causes Syncytia Formation with Bioenergetic Celi Death: Implications for Gene Therapy. Cancer Res. 60, 6396-6402.

Hoffmann, M., Wu, Y.-J., Gerber, M., Berger-Rentsch, M., Heimrich, B., Schwemmle, M., and Zimmer, G. (2010). Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. J. Gen. Virol. 91, 2782-2793.

Janelle, V., Brassard, F., Lapierre, P., Lamarre, A., and Poliquin, L. (2011). Mutations in the Glycoprotein of Vesicular Stomatitis Virus Affect Cytopathogenicity: Potential for Oncolytic Virotherapy. J. Virol. 85, 6513-6520.

Jayakar, H.R., Jeetendra, E., and Whitt, M.A. (2004). Rhabdovirus assembly and budding. Yirus Res. 106, 117-132.